案例报告:当多个系统缩伪装成CASPR2自身免疫脑病变时:一个诊断陷
Jun Zhang1, Yueming Wang2, Le Chen2
1Clinical Research Center, Xuanwu Hospital Capital Medical University, Beijing, China.
Frontiers in human neuroscience
|October 1, 2025
概括
早期诊断多系统性缩 (MSA) 是一个挑战. 这一案例强调,虽然CASPR2抗体可能存在,但整体临床情况,包括EAS-EMG检测到的亚临床自主功能障碍,对于准确的MSA诊断至关重要.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
背景情况:
- 多重系统缩 (MSA) 是一种进展性神经退行性疾病,具有具有挑战性的早期诊断.
- 卡斯普2抗体可能会使早期诊断复杂化,特别是在小脑亚型 (MSA-C) 中.
研究的目的:
- 报告一个MSA-C病例,最初呈现出CASPR2抗体.
- 强调全面临床评估对于诊断MSA的重要性.
主要方法:
- 一个56岁的女性患有小脑缩症的案例介绍.
- 对CASPR2抗体和脑MRI的血清分析.
- 外部门线电肌图 (EAS-EMG) 用于评估自主功能.
主要成果:
- 患者呈现了小脑动力衰竭和CASPR2抗体.
- 大脑MRI显示脑干和小脑缩.
- EAS-EMG检测到亚临床自主功能障碍,后来证实为MSA-C,尽管最初缺乏免疫抑制剂的改善.
结论:
- 可以通过EAS-EMG检测到的亚临床自主功能障碍对于早期MSA诊断至关重要.
- 仅仅依靠抗体存在可能会误导;整体临床表现至关重要.
- MSA-C和CASPR2抗体的同时出现是罕见的,但强调需要彻底的诊断工作.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...


